Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Chlamydia trachomatis | thymidylate kinase | 0.057 | 1 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.057 | 1 | 1 |
Echinococcus multilocularis | thymidylate kinase | 0.057 | 1 | 1 |
Trypanosoma brucei | thymidylate kinase, putative | 0.057 | 1 | 0.5 |
Trichomonas vaginalis | thymidylate kinase, putative | 0.057 | 1 | 0.5 |
Leishmania major | thymidylate kinase-like protein | 0.057 | 1 | 1 |
Mycobacterium ulcerans | thymidylate kinase | 0.057 | 1 | 0.5 |
Mycobacterium leprae | probable thymidylate kinase Tmk (dTMP KINASE) (THYMIDYLIC ACID KINASE) (TMPK) | 0.057 | 1 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | thymidylate kinase | 0.057 | 1 | 0.5 |
Trichomonas vaginalis | thymidylate kinase, putative | 0.057 | 1 | 0.5 |
Plasmodium vivax | thymidylate kinase, putative | 0.057 | 1 | 0.5 |
Echinococcus granulosus | thymidylate kinase | 0.057 | 1 | 1 |
Schistosoma mansoni | thymidylate kinase | 0.057 | 1 | 1 |
Schistosoma mansoni | thymidylate kinase | 0.057 | 1 | 1 |
Giardia lamblia | CDC8 | 0.057 | 1 | 0.5 |
Entamoeba histolytica | Thymidylate kinase, putative | 0.057 | 1 | 0.5 |
Treponema pallidum | thymidylate kinase (tmk) | 0.057 | 1 | 0.5 |
Toxoplasma gondii | thymidylate kinase | 0.057 | 1 | 0.5 |
Plasmodium falciparum | thymidylate kinase | 0.057 | 1 | 0.5 |
Trypanosoma cruzi | thymidylate kinase, putative | 0.057 | 1 | 1 |
Mycobacterium tuberculosis | Thymidylate kinase Tmk (dTMP kinase) (thymidylic acid kinase) (TMPK) | 0.057 | 1 | 0.5 |
Loa Loa (eye worm) | thymidylate kinase | 0.057 | 1 | 0.5 |
Onchocerca volvulus | Putative thymidylate kinase | 0.057 | 1 | 0.5 |
Trypanosoma brucei | thymidylate kinase, putative | 0.057 | 1 | 0.5 |
Trypanosoma cruzi | thymidylate kinase, putative | 0.057 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.